Growth Metrics

Palvella Therapeutics (PVLA) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - 1,961.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,961.87%
Dec 31, 2025 -107.16%
Sep 30, 2025 -3,962.77%
Jun 30, 2025 -148.57%
Mar 31, 2025 -200.91%
Dec 31, 2024 661.29%
Sep 30, 2024 98.39%
Jun 30, 2024 109.97%
Mar 31, 2024 770.78%
Dec 31, 2023 177.69%
Sep 30, 2023 -286.88%
Jun 30, 2023 119.05%
Mar 31, 2023 102.75%
Dec 31, 2022 -83.76%
Sep 30, 2022 -142.73%
Jun 30, 2022 -150.03%
Mar 31, 2022 -1,235.75%
Dec 31, 2021 -523.13%
Sep 30, 2021 -65.29%
Jun 30, 2021 1,488.58%
Mar 31, 2021 83.20%
Dec 31, 2020 -90.46%
Sep 30, 2020 345.61%
Jun 30, 2020 -253.15%
Mar 31, 2020 27.94%
Dec 31, 2019 210.81%
Sep 30, 2019 -121.13%
Jun 30, 2019 104.26%
Mar 31, 2019 -128.68%
Dec 31, 2018 70.79%
Sep 30, 2018 6.44%
Jun 30, 2018 -908.43%
Mar 31, 2018 178.23%
Dec 31, 2017 -601.08%
Sep 30, 2017 1,063.65%
Jun 30, 2017 -162.76%
Mar 31, 2017 1,206.62%
Dec 31, 2016 -145.86%
Sep 30, 2016 -117.39%
Jun 30, 2016 388.39%
Mar 31, 2016 141.13%
Sep 30, 2015 87,480.51%
Jun 30, 2015 -44.48%
Mar 31, 2015 -1,034.12%
Sep 30, 2014 -459.15%
Jun 30, 2014 -42,164.29%